Estee Lauder Companies (EL) & DS Healthcare Group (DSKX) Head-To-Head Analysis

Estee Lauder Companies (NYSE: EL) and DS Healthcare Group (OTCMKTS:DSKX) are both non-cyclical consumer goods & services companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk and valuation.

Risk and Volatility

Estee Lauder Companies has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500. Comparatively, DS Healthcare Group has a beta of 2.31, indicating that its share price is 131% more volatile than the S&P 500.

Institutional and Insider Ownership

53.6% of Estee Lauder Companies shares are held by institutional investors. Comparatively, 0.0% of DS Healthcare Group shares are held by institutional investors. 16.2% of Estee Lauder Companies shares are held by company insiders. Comparatively, 19.4% of DS Healthcare Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.


Estee Lauder Companies pays an annual dividend of $1.52 per share and has a dividend yield of 1.2%. DS Healthcare Group does not pay a dividend. Estee Lauder Companies pays out 41.1% of its earnings in the form of a dividend. Estee Lauder Companies has increased its dividend for 4 consecutive years.

Analyst Ratings

This is a summary of recent recommendations for Estee Lauder Companies and DS Healthcare Group, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Estee Lauder Companies 0 6 16 0 2.73
DS Healthcare Group 0 0 0 0 N/A

Estee Lauder Companies currently has a consensus price target of $118.17, indicating a potential downside of 8.46%. Given Estee Lauder Companies’ higher possible upside, equities research analysts clearly believe Estee Lauder Companies is more favorable than DS Healthcare Group.


This table compares Estee Lauder Companies and DS Healthcare Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Estee Lauder Companies 11.30% 33.64% 12.39%
DS Healthcare Group -62.31% -1,304.25% -117.85%

Valuation & Earnings

This table compares Estee Lauder Companies and DS Healthcare Group’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Estee Lauder Companies $11.82 billion 4.02 $1.25 billion $3.70 34.89
DS Healthcare Group $12.95 million 0.01 -$6.93 million ($0.27) -0.02

Estee Lauder Companies has higher revenue and earnings than DS Healthcare Group. DS Healthcare Group is trading at a lower price-to-earnings ratio than Estee Lauder Companies, indicating that it is currently the more affordable of the two stocks.


Estee Lauder Companies beats DS Healthcare Group on 13 of the 16 factors compared between the two stocks.

Estee Lauder Companies Company Profile

The Estee Lauder Companies Inc. manufactures and markets skin care, makeup, fragrance and hair care products. The Company offers products, including skin care, makeup, fragrance, hair care and other. The Company operates in beauty products segment. The Company’s products are sold in over 150 countries and territories under brand names, including Estee Lauder, Aramis, Clinique, Prescriptives, Lab Series, Origins, Tommy Hilfiger, MAC, Kiton, La Mer, Bobbi Brown, Donna Karan New York, DKNY, Aveda, Jo Malone London, Bumble and bumble, Michael Kors, Darphin, Tom Ford, Smashbox, Ermenegildo Zegna, AERIN, Tory Burch, RODIN olio lusso, Le Labo, Editions de Parfums Frederic Malle, GLAMGLOW, By Kilian, BECCA and Too Faced. Its skin care products include moisturizers, serums, cleansers, toners, body care, exfoliators, acne and oil correctors, facial masks, cleansing devices and sun care products.

DS Healthcare Group Company Profile

DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. Its technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells. The Company products are primarily sold under its DS Laboratories brand. It also sells certain products under its Polaris Labs and Sigma Skin brands. It markets and sells these products through salons, spas, department stores, specialty retailers and distributors. The Company offers products under three product categories: Hair Care, Skin Care and Personal Care.

Receive News & Ratings for Estee Lauder Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Estee Lauder Companies and related companies with's FREE daily email newsletter.

Leave a Reply